Even by DLX's standards, a very good quality result, with growth in all business units (yes, even the garage doors division):
1H2017 EBIT Growth:
Paints & Coatings [84% of Group EBIT]: +7.7% (Rev +4.7%, Margin +50bp to 18.7%)
Consumer & Construction [13% of Group EBIT]: +11.9% (Rev +0.1%, Margin +110bp to 10.9%)
Garage Doors & Openers [6% of Group EBIT]: +5.8% (Rev +2.4%, Margin +20bp to 7.1%)
Cabinet and Architectural Hardware [6% of Group EBIT]: +22.4% (Rev +5.3%, Margin +70bp to 7.7%)
Other [6% of Group EBIT]: -19.6% (Rev +2.3%, Margin -150bp to 5.4%)
Corporate Expenses [-14% of Group EBIT]: +5.3%
The only blemish was the contraction in the "Other" segment but I'll wager this was overwhelmingly due to cost investment to support future growth in the recently-acquired UK paint business. If you "normalise" for this ~$1.0m cost investment then that division's EBIT declined by 5%.
On the other hand, the result was boosted by higher than normal "Other Revenue" (no details provided) which was $2.5m in the half, compared to normal levels that average around $1.0m per half-year.
In terms of cash flow, the company still managed to break even at the Free cash flow level, despite:
- the March half-years being seasonally weaker in Operating Cash Flow terms (usually, just 25% of OCF is generated in Marhc half-years, and 75% of OCF is generated in September halves), and
- the increased capex for the new paint factory, which is on track, on time and within budget.
As a result of the strong cash flow performance, Net Debt came in at $399m (compared to my expectation of between $420m to $440m).
Consequently, NIBD-to-EBITDA now looks like it will peak at an undemanding 1.5x (compared to my earlier forecast of 1.7x)
This all led to the board declaring a 13% increase in the dividend, to 13c.
It is truly a high-quality, durable business with a wide (and widening) commercial moat.
Only trouble, I think, is that - at 20x P/E and 12x EV/EBITDA - it is sort of priced that way.
So while I think the market will be very happy with yet another excellent DLX result, I don't think the stock price will be going anywhere in a hurry.
..
- Forums
- ASX - By Stock
- DLX
- Ann: Half Year Report 2017 - Appendix 4D
Ann: Half Year Report 2017 - Appendix 4D, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online